Effect of NMN (Nicotinamide Mononucleotide) on Polycystic Ovary Syndrome
Condition(s):Polycystic Ovary SyndromeLast Updated:May 31, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Polycystic Ovary SyndromeLast Updated:May 31, 2023Recruiting
Condition(s):Diminished Ovarian Reserve; Premature Ovarian InsufficiencyLast Updated:October 12, 2022Recruiting
Condition(s):AgingLast Updated:April 1, 2021Completed
Condition(s):Glucose Metabolism DisordersLast Updated:July 14, 2021Completed
Condition(s):Binge Drinking; Liver Injury; Nutritional Supplementation; Hepatic SteatosisLast Updated:March 4, 2024Active, not recruiting
Condition(s):Healthy VolunteersLast Updated:March 30, 2023Completed
Condition(s):Healthy VolunteersLast Updated:January 26, 2023Completed
Condition(s):AgingLast Updated:October 1, 2021Completed
Condition(s):Glucose Metabolism DisordersLast Updated:June 15, 2023Recruiting
Condition(s):Postoperative Prevention of TumorLast Updated:September 13, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.